10/9
09:31 am
vrpx
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) had its "hold" rating re-affirmed by analysts at Maxim Group.
Low
Report
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) had its "hold" rating re-affirmed by analysts at Maxim Group.
10/9
09:24 am
vrpx
Rating for VRPX
Medium
Report
Rating for VRPX